Trials
Search / Trial NCT05650151

Peri-operative Vitamin D Therapy for Hepatectomy

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Dec 6, 2022

Trial Information

Current as of January 21, 2025

Unknown status

Keywords

Vitamin D Therapy Hepatocellular Carcinoma Perioperative Complication

ClinConnect Summary

Participants will receive short-term high dose of vitamin D during perioperative period.

The main questions the study aims to answer are:

1. If vitamin D therapy benefits perioperative care
2. If short-term high dose of vitamin D supplement is safe

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients older than 20 years
  • Patients will undergo hepatectomy for hepatocellular carcinoma.
  • Exclusion Criteria:
  • Patients with hypercalcemia, hyperparathyroidism, sarcoidosis, multiple myeloma

Trial Officials

Yin-Yi Han, PHD

Principal Investigator

National Taiwan University Hospital

About National Taiwan University Hospital

National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials